Bay Area biotechs soar on coattails of AstraZeneca cancer drug study

/Bay Area biotechs soar on coattails of AstraZeneca cancer drug study

Bay Area biotechs soar on coattails of AstraZeneca cancer drug study

Shares of a Bay Area biotech company shot up more than 157% and another climbed to a lesser degree Friday after a Big Pharma company reported that a cancer drug with a shared target appeared effective in fighting tumors. Both Corvus Pharmaceuticals Inc. (Nasdaq: CRVS) of Burlingame and Arcus Biosciences Inc. (NYSE: RCUS) of Hayward shot up after AstraZeneca plc reported fresh data from a mid-stage clinical trial. That Big Pharma player said its already-approved cancer immunotherapy Imfinzi showed…

Article by [author-name] (c) Health Care News - Health Care News Headlines | Bizjournals.com - Read full story here.

By | 2021-09-17T21:59:07+00:00 September 17th, 2021|Uncategorized|

About the Author: